DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 42 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 7.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -33.3% | 1,300 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $3,000 | -25.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $4,000 | -20.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | -50.0% | 1,300 | -43.5% | 0.00% | -50.0% |
| Q2 2021 | $10,000 | -88.1% | 2,300 | -75.0% | 0.00% | -89.5% |
| Q1 2021 | $84,000 | +950.0% | 9,203 | +234.7% | 0.02% | +375.0% |
| Q1 2020 | $8,000 | -38.5% | 2,750 | 0.0% | 0.00% | -20.0% |
| Q4 2019 | $13,000 | +225.0% | 2,750 | +37.5% | 0.01% | +150.0% |
| Q3 2019 | $4,000 | -60.0% | 2,000 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $10,000 | -28.6% | 2,000 | -33.3% | 0.00% | -42.9% |
| Q1 2019 | $14,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 325,000 | $1,404,000 | 2.87% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 198,730 | $858,514 | 0.97% |
| Bleichroeder LP | 294,117 | $1,270,585 | 0.26% |
| EAM Investors, LLC | 270,419 | $1,168,210 | 0.22% |
| COOPERMAN LEON G | 875,993 | $3,784,290 | 0.20% |
| CATALYST FINANCIAL PARTNERS LLC | 36,267 | $156,673 | 0.06% |
| Legend Financial Advisors, Inc. | 1,000 | $4,320 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 124,744 | $538,894 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,240 | $26,957 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 4,824 | $20,840 | 0.00% |